Concepedia

Peter Capitelli

PC

Statistics

Publications

4

Citations

267

H-Index

4

Active since

1995

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Peter Capitelli is an author at Memorial Sloan Kettering Cancer Center specializing in cancer therapeutics, tumor microenvironment, and oncology.

Top concepts

Publications per year

1995–1998

4

Publications

4

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.

Chaitanya Divgi, Neil H. Bander, Andrew M. Scott et al. · PubMed · 1998 · 157 citations

, , +14

Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.

Chaitanya Divgi, Andrew M. Scott, L Dantis et al. · PubMed · 1995 · 77 citations

Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma.

C R Divgi, Andrew M. Scott, Sadi Güleç et al. · PubMed · 1995 · 23 citations

, , +14

Pharmacokinetic model of iodine-131-G250 antibody in renal cell carcinoma patients.

Angela Loh, George Sgouros, Joseph A. O’Donoghue et al. · PubMed · 1998 · 10 citations

1–4 of 4